Status:
COMPLETED
Combination of Glinides With Premixed Insulin
Lead Sponsor:
Keio University
Conditions:
Type 2 Diabets Mellitus
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
Combination therapy of glinides with premixed insulin provides better glycemic control than premixed insulin alone.
Detailed Description
Type 2 diabetic patients undergoing twice daily injections of premixed insulin are administered glinides (10mg of mitiglinide or 90 mg of nateglinide) at lunchtime without changing their insulin regim...
Eligibility Criteria
Inclusion
- Clinical diagnosis of type 2 diabetes
- Who undergoes twice daily injection of premixed insulin
- Whose HbA1c is more than 6.5% and less than 8.0%
Exclusion
- Whose change of HbA1c is more than 1.0% during 12 weeks observational period
Key Trial Info
Start Date :
July 1 2004
Trial Type :
INTERVENTIONAL
End Date :
March 1 2006
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00369148
Start Date
July 1 2004
End Date
March 1 2006
Last Update
August 26 2009
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Nippon Kokan Hospital
Kawasaki, Kanagawa, Japan, 210-0852
2
Hamamatsu Red Cross Hospital
Hamamatsu, Shizuoka, Japan, 430-0907
3
Saiseikai Central Hospital
Minato-ku, Tokyo, Japan, 108-0073
4
Kitasato Institute Hospital
Minato-ku, Tokyo, Japan, 108-8642